V. Mazzaferro

Hepatology · 2007–2021

A researcher in the Science corpus: 17 papers; trusts 4 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom V. Mazzaferro trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Llovet
  2. Jordi Bruix1 , 2

Who trusts V. Mazzaferro overall

  1. Jordi Bruix1 , 2
  2. J. Llovet

Papers from V. Mazzaferro's perspective

Ordered by how strongly the researchers V. Mazzaferro trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
  2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  3. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  4. INCIDENCE OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED RISK FACTORS IN HEPATITIS C-RELATED ADVANCED LIVER DISEASE (Gastroenterology)
  5. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
  6. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  7. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial (Annals of Surgery)
  8. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. (American Journal of Epidemiology)
  9. Noninvasive assessment of liver fibrosis (Hepatology)
  10. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. (Journal of the American College of Surgeons)

Their papers